# US 2019/0291105 A1 · A nano/micropatterned nuclear deformation based cellular diagnostic system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0291105 A1
- Document ID: US20190291105A1
- Status: Published application
- Kind: A1
- Application number: 16/346,197
- Filed: 2017-10-06
- Published: 2019-09-26
- Earliest claimed: 2016-10-31
- Assignees: Vasif Nejat HASIRCI; Utkan DEMIRCI
- Inventors: Vasif Nejat HASIRCI; Utkan DEMIRCI; Menekse ERMIS SEN; Derya AKKAYNAK
- Web page: https://patentgrep.com/patent/US20190291105A1

## CPC

- B01L 3/502715: {characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces}
- B01L 3/502707: {characterised by the manufacture of the container or its components}
- B01L 3/5088: {confining liquids at a location by surface tension, e.g. virtual wells on plates, wires (B01L3/50857 takes precedence)}
- C12M 23/00: {Constructional details, e.g. recesses, hinges (flow directing inserts in C12M27/18-C12M27/24; apparatus for chemical or physical processes in general B01J, chemical or physical laboratory apparatus in general B01L)}
- C12M 23/20: {Material Coatings (immunocoatings C12M25/00)}
- G01N 33/48: Biological material, e.g. blood, urine (G01N33/02, G01N33/26, G01N33/44, G01N33/46 take precedence); Haemocytometers (counting blood corpuscules distributed over a surface by scanning the surface G06M11/02)
- G06T 7/0012: {Biomedical image inspection}
- B01L 2200/0663: Stretching or orienting elongated molecules or particles
- B01L 2300/0819: Microarrays; Biochips
- B01L 2300/123: Flexible; Elastomeric
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- B82Y 40/00: Manufacture or treatment of nanostructures
- G01N 2800/7028: Cancer
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G06T: IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

A diagnostic method for a detection of a nuclear deformation based a cellular differentiation includes the following steps: preparing nano/micropatterned surfaces; performing a cell seeding on the nano/micropatterned surfaces; imaging; analyzing nuclear deformations of a single cell and a cell population with an algorithm method.

## Claims

### Claim 1

A diagnostic method for a detection of a nuclear deformation based a cellular differentiation, comprising the following steps:
a) preparing nano/micropatterned surfaces:
1) placing a silicon wafer produced by a photolithography or an ion beam lithography into a container,
2) pouring poly(dimethyl siloxane) (PDMS) onto the silicon wafer and curing the silicon wafer with the PDMS in an oven,
3) solidifying a PDMS mold during curing, and peeling off the PDMS mold from the silicon wafer,
4) using a PDMS replica as a frame, and
i) pouring a biodegradable polymer solution or a nondegradable polymer solution into the PDMS replica, and evaporating a solvent, or
ii) hot embossing the PDMS replica with a pre-prepared polymer film, or
iii) directly on the silicon wafer,
5) performing a crosslinking step on polymers requiring a chemical or photocrosslinking;
b) performing a cell seeding on the nano/micropatterned surfaces;
c) imaging:
putting the nano/micropatterned surfaces with cells on a top as samples for an imaging,
staining each sample of the samples with a nucleus or a DNA dye, and
imaging the each sample with a confocal laser scanning or a fluorescence microscope;
d) analyzing nuclear deformations of a single cell and a cell population with an algorithm method comprising the following steps:
reading an image in a RGB format,
converting the RGB format to a gray scale,
detecting cell nuclei in the image,
excluding cell nuclei with low signal intensity,
getting binary images using an Otsu method,
excluding cell nuclei at four borders of the binary images,
excluding very large and very small nuclei,
detecting cell nuclei going through a cell division with a watershed transformation, and excluding cell in mitosis,
after a quality control, smoothing remaining cell nuclei images by using a Gaussian filter to even rough pixel edges,
applying morphological to eliminate any artefacts,
rotating each nucleus by orienting a major axis of the each nucleus to a y-axis, and ensuring a centroid is always on a right side of the major axis,
for a scale invariance, scaling a longest dimension of an image of the each nuclei to 64 pixels while preserving an aspect ratio,
cleaning a noise with a low cut filter, and/or a morphological opening, and/or a median filter,
excluding nuclei that occupy 100% of bounding boxes of the nuclei, and the nuclei are clearly artefacts,
calculating a rectangularity (R) of the nucleus:
R
=

π
4
-
A
cell
A
bounding


box

calculating a circle variance (CV):
μ
R
=
1
N

∑
i
=
1
N
-
i

d
i
,

σ
R
=
1
N

∑
i
=
1
N
-
i

(
d
i
-
μ
R
)
2
,

CV
=
σ
R
μ
R
calculating a deformation score (DS).

### Claim 2 (depends on 1)

The diagnostic method according to claim 1, wherein the cells are cultured after the cell seeding from 4 hours to 21 days.

### Claim 3 (depends on 1)

The diagnostic method according to claim 1, wherein the cells are seeded as the single cell or the cell population.

### Claim 4 (depends on 1)

The diagnostic method according to claim 1, wherein the samples are imaged after a fixation or in alive.

### Claim 5 (depends on 4)

The diagnostic method according to claim 4, wherein the samples fixed by alcohol, paraformaldehyde, formaldehyde or glutaraldehyde.

### Claim 6 (depends on 1)

The diagnostic method according to claim 1, wherein the nano/micropatterned surfaces are made from a biodegradable polymer or a nonbiodegradable polymer.

### Claim 7 (depends on 1)

The diagnostic method according to claim 1, wherein the nano/micropatterned surfaces are made using the PDMS mold and a solvent casting and evaporation of the biodegradable polymer solution and the nonbiodegradable polymer solution.

### Claim 8 (depends on 1)

The diagnostic method according to claim 1, wherein the nano/micropatterned surfaces are made using the silicon wafer as a mold and a solvent casting and evaporation of the biodegradable polymer solution and the nonbiodegradable polymer solution.

### Claim 9 (depends on 1)

The diagnostic method according to claim 1, wherein the nano/micropatterned surfaces are made using the PDMS mold and the hot embossing of the pre-prepared polymer film.

### Claim 10 (depends on 1)

The diagnostic method according to claim 1, wherein the nano/micropatterned surfaces are made using the silicon wafer as a template and the hot embossing of the pre-prepared polymer film.

### Claim 11 (depends on 1)

The diagnostic method according to claim 1, wherein the nano/micropatterned surfaces are made from poly(lactic acid-co-glycolic acid) (PLGA), polylactic acid (PLA), poly(methyl methacrylate) (PMMA), poly(hydroxyethyl methacrylate) (PHEMA), or polyacrylamide (PAAm).

### Claim 12

(canceled)

### Claim 13

(canceled)

### Claim 14 (depends on 1)

The diagnostic method according to claim 1, wherein the nano/micropatterned surfaces are sterilized with gamma irradiation, UV or ethylene oxide.

### Claim 15

A nano/micropatterned diagnostic chip, wherein the nano/micropatterned diagnostic chip is prepared by a method comprising the following steps:
preparing nano/micropatterned surfaces:
1) placing a silicon wafer produced by a photolithography or an ion beam lithography into a container,
2) pouring poly(dimethyl siloxane) (PDMS) onto the silicon wafer and curing the silicon wafer with the PDMS in an oven,
3) solidifying a PDMS mold during curing, and peeling off the PDMS mold from the silicon wafer,
4) using a PDMS replica as a frame, and
i) pouring a biodegradable polymer solution or a nondegradable polymer solution into the PDMS replica, and evaporating a solvent, or
ii) hot embossing the PDMS replica with a pre-prepared polymer film, or
iii) directly on the silicon wafer,
5) performing a crosslinking step on polymers requiring a chemical or photocrosslinking; and
placing the nano/micropatterned surfaces to a microfluidics chip to obtain the nano/micropatterned diagnostic chip.

### Claim 16 (depends on 15)

A method of diagnosing a disease, comprising: using the nano/micropatterned diagnostic chip according to claim 15.

### Claim 17 (depends on 15)

A method of diagnosing a cancer, comprising: using the nano/micropatterned diagnostic chip according to claim 15.
